MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5826/dpc.1302a151

Медицинская библиотека · Dermatology practical & conceptual · 2023

Real-World Experience With Topical 5-Fluorouracil 4% (40 mg/g) Cream for the Treatment of Actinic Keratosis.

Briatico Giulia, Brancaccio Gabriella, Scharf Camila, Di Brizzi Eugenia Veronica, Pellerone Sebastiano, Caccavale Stefano, Giorgio Caterina Mariarosaria, Procaccini Enrico Maria, Moscarella Elvira, Argenziano Giuseppe

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

5-fluorouracil (5-FU) is one of the most effective topical treatments for actinic keratosis (AK). A new 4% formulation of 5-FU was recently approved in Europe.

OBJECTIVES

This study aimed at evaluating 4% 5-FU cream safety and effectiveness in a real-world setting.

METHODS

Adult AK patients were retrospectively selected from the University of Campania Dermatology Unit database. Selection criteria included a diagnosis of non-hyperkeratotic, non-hypertrophic AK (Olsen grade I and II) of the face, ears, and/or scalp, treatment with 4% 5-FU once daily for 4 weeks, and at least 3 follow-up visits (4 and 8 weeks after treatment initiation, and 6 months after treatment end). The primary objectives were to evaluate AK lesions improvement at 8 weeks and relapse rate at 6 months. Patient-reported erythema and burning sensation intensity were also assessed at 4 weeks.

RESULTS

Ninety-eight patients were included in this analysis (male/female 80/18, mean age 74.7 years). AK lesions improvement at 8 weeks resulted complete or significant in 74.5% and 20.4% of the patients, respectively. At 6 months, 65.3% of the patients did not show AK relapses. Burning sensation at 4 weeks was reported as light, moderate, or absent by 44.9%, 22.4%, and 31.6% of the patients, respectively. Erythema was reported as light, moderate, or absent by 37.8%, 51%, and 10% of the patients, respectively. Burning sensation and erythema disappeared gradually during follow-up. No other side effects were reported.

CONCLUSIONS

In this real-world study 4% 5-FU proved to be highly effective for AK lesions clearance with a favorable safety profile.

Для цитирования: Briatico Giulia, Brancaccio Gabriella, Scharf Camila, Di Brizzi Eugenia Veronica, Pellerone Sebastiano, Caccavale Stefano, Giorgio Caterina Mariarosaria, Procaccini Enrico Maria, Moscarella Elvira, Argenziano Giuseppe. Real-World Experience With Topical 5-Fluorouracil 4% (40 mg/g) Cream for the Treatment of Actinic Keratosis.. Dermatology practical & conceptual. 2023. DOI: 10.5826/dpc.1302a151.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.